0001209191-17-041852.txt : 20170626 0001209191-17-041852.hdr.sgml : 20170626 20170626165533 ACCESSION NUMBER: 0001209191-17-041852 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170622 FILED AS OF DATE: 20170626 DATE AS OF CHANGE: 20170626 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PURE BIOSCIENCE, INC. CENTRAL INDEX KEY: 0001006028 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS CHEMICAL PRODUCTS [2890] IRS NUMBER: 330530289 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 1725 GILLESPIE WAY CITY: EL CAJON STATE: CA ZIP: 92020 BUSINESS PHONE: 619-596-8600 MAIL ADDRESS: STREET 1: 1725 GILLESPIE WAY CITY: EL CAJON STATE: CA ZIP: 92020 FORMER COMPANY: FORMER CONFORMED NAME: PURE BIOSCIENCE DATE OF NAME CHANGE: 20031029 FORMER COMPANY: FORMER CONFORMED NAME: PURE BIOSCIENCES DATE OF NAME CHANGE: 20031029 FORMER COMPANY: FORMER CONFORMED NAME: INNOVATIVE MEDICAL SERVICES DATE OF NAME CHANGE: 19960122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lee Tom Y CENTRAL INDEX KEY: 0001623609 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14468 FILM NUMBER: 17930387 MAIL ADDRESS: STREET 1: 1807 SAN GABRIEL BLVD. CITY: SAN GABRIEL STATE: CA ZIP: 91776 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-06-22 0 0001006028 PURE BIOSCIENCE, INC. PURE 0001623609 Lee Tom Y 1807 SAN GABRIEL BLVD. SAN GABRIEL CA 91776 1 0 0 0 Common Stock 2017-06-22 4 A 0 150000 0.00 A 3834452 D Stock Option (Right to Buy) 1.19 2017-06-22 4 A 0 200000 0.00 A 2027-06-22 Common Stock 200000 200000 D Represents the issuance of restricted stock units (the "RSUs"). The RSUs vest as follows: (i) 50% of the RSUs will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2018 or January 15, 2018 and (ii) 50% of the RSUs will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019. Vested shares will be delivered to the Reporting Person on the earlier of (i) the ten-year anniversary of the Grant Date; (ii) sixty days after the date the Grantee's Service ceases for any reason and such cessation constitutes a "separation from service" within the meaning of Section 409A of the Code; (iii) the date of Grantee's death or (iv) the date of a Change in Control that constitutes a "change in control event" within the meaning of Section 409A of the Code. The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2018 or January 15, 2018 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019. /s/ Tom Lee 2017-06-26